Trend in prevalence, associated risk factors, and longitudinal outcomes of sarcopenia in China: A national cohort study
Journal of Internal Medicine · 2024-08 · 296 (2) · 156-167
DOI: 10.1111/joim.13808 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Internal Medicine, online erschienen am 27.05.2024. Verfasst von Weida Qiu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Aca…. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Key Area R&D Program of Guangdong Province, Climbing Plan of Guangdong Provincial People's Hospital, Guangdong Provincial Clinical Research Center for Cardiovascular Disease.
Abstract (Originalsprache)
Aims
To estimate the contemporary trend in the prevalence of sarcopenia and evaluate its risk factors and the longitudinal associations with multiple chronic conditions and mortality among Chinese middle‐aged and older adults.
Methods
This was a nationwide, prospective cohort study using data from the China Health and Retirement Longitudinal Study. The definition of sarcopenia was based on the Asian Working Group for Sarcopenia 2019 algorithm. In the cross‐sectional analysis, we estimated the trend in the weighted prevalence of sarcopenia from 2011 to 2015 and examined the associated risk factors for sarcopenia severity in 2011. In the longitudinal analysis, we assessed the longitudinal associations between sarcopenia and 14 chronic conditions and mortality during a 9‐year follow‐up.
Results
The weighted prevalence of sarcopenia remained consistently high in the overall population from 2011 (15.9%, 95% confidence intervals [CI]: 15.1, 16.6) to 2015 (15.0%, 95% CI: 14.3, 15.6; p for trend = 0.075). A range of risk factors were independently associated with the severity of sarcopenia, including older age, female sex, lower socioeconomic status, smoking status, malnutrition, and several chronic conditions. Possible sarcopenic and sarcopenic individuals had higher odds of several chronic conditions (i.e., heart disease, chronic lung disease, and memory‐related disease) and increased risks of mortality (possible sarcopenia: odds ratios (OR): 1.66, 95% CI: 1.37, 2.00; sarcopenia: OR: 1.69, 95% CI: 1.36, 2.11) in 9 years of follow‐up.
Conclusions
The prevalence of sarcopenia remained consistently high in the investigated population. Various risk factors were significantly associated with a higher prevalence of sarcopenia. Sarcopenic individuals had higher odds of several chronic conditions and increased risks of mortality, highlighting that the urgent need for dedicated efforts to improve the management of sarcopenic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Chin…
ORCID-Profile: Weida Qiu
Förderung
- Key Area R&D Program of Guangdong Province
- Climbing Plan of Guangdong Provincial People's Hospital
- Guangdong Provincial Clinical Research Center for Cardiovascular Disease
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention
Zitieren
APA
Qiu, W., Cai, A., Li, L., & Feng, Y. (2024). Trend in prevalence, associated risk factors, and longitudinal outcomes of sarcopenia in China: A national cohort study. Journal of Internal Medicine, 296(2), 156-167. https://doi.org/10.1111/joim.13808
Vancouver
Qiu W, Cai A, Li L, Feng Y. Trend in prevalence, associated risk factors, and longitudinal outcomes of sarcopenia in China: A national cohort study. Journal of Internal Medicine. 2024;296(2):156-167. doi:10.1111/joim.13808
BibTeX
@article{Qiu2024,
author = {Qiu, Weida and Cai, Anping and Li, Liwen and Feng, Yingqing},
title = {Trend in prevalence, associated risk factors, and longitudinal outcomes of sarcopenia in China: A national cohort study},
journal = {Journal of Internal Medicine},
year = {2024},
volume = {296},
number = {2},
pages = {156--167},
doi = {10.1111/joim.13808}
}
EUVIMED